Best chemotherapy doctor hospital india

[vc_row][vc_column][vc_column_text]

DR. GANESHA DEV VASHISHTA – SR. CONSULTANT – MEDICAL ONCOLOGY [CHEMOTHERAPY]

QUALIFICATIONS

MBBS 1985-1991 Bangalore Medical College,Bangalore.
M.D.(Int. Med) 1992-1995 Karnataka Medical College,Hubli.
D.M.(Med.Oncology) 1998-2000 Kidwai Memorial Instiute Of Oncology, Bangalore, India. (A Regional Cancer Institute recognised by the UICC).
Assistant Professor 2000- 2001 Dept. Of Med. Oncology, Sri Devraj Urs Medical College, Kolar.
Consultant Medical Oncologist Since 2001 Curie Center of Oncology, St. John’s Medical College And Hospital Campus Koramangala, Bangalore-560034
Senior Consultant Medical Oncologist Since 2010 Apollo hospitals, Bangalore .
Head, Dept of Medical oncology &BMT Since 2012 BGS hospitals, Bangalore

TEACHING EXPERIENCE

2004(Dec) till date

Visiting Faculty for Post graduates of Swami Vivekananda Yoga Anusandhana Samsthana (Deemed University).

2002 till date

Theory and clinical classes with journal club for post graduates of St. John’s Medical College and KIMS in Obstetrics and Gynecology.
Theory classes for Bsc Nursing students from College of Nursing St. John’s National Academy of Health Sciences

2000-2001

Theory and clinical classes for post graduates and graduate Medical students Sri Devaraj Urs Medical College, Kolar

1998-2000

During the DM course, Theory and clinical classes for post graduates students of General Medicine and Pediatrics.

INTERNATIONAL CONFERENCES ATTENDED

XV Asia Pacific Cancer Conference, Chennai, India.
Dec 12 – 15, 1999.

  • 4th Lilly Onco Update, 3rd – 5th August 2001 held at Goa.
  • Annual meeting of ASCO, 18th – 21st May 2002 at Orlando, Florida for poster presentation (Phase-II Clinical Trial Results of 3 drug regimen of Cisplatin+Paclitaxel+Gemcitabine as first line, in Advanced and Metastatic Ovarian Epithelial Cancers)
  • Asia Pacific Oncology Conference at Bali, Indonesia August 2003.
  • Oncology Conference at Dubai January 2004.
  • Oncology Conference at Singapore, February 2nd –3rd 2004.
  • Good Clinical Practice Workshop- Investigators Meeting at Dubai, March 4th 2004.
  • European Society of Medical Oncology (ESMO) conference held at Vienna, Austria, Oct 28-Nov 2, 2004.
  • Annual meeting of ASCO 2003, 2005, 2007, 2009
  • European Society of Medical Oncology (ESMO) 2006, 2008, 2010

PUBLISHED ARTICLES

  • Clinical Study of acute exacerbation of Chronic Bronchitis. Accepted as M.D. thesis, Karnataka University, Dharwad.
  • Efficacy of IV Human Albumin in preventing Chemotherapy induced tiredness A Pilot clinical Trial, Karnataka Journal of Medical Sciences (Oct – Dec 1998) 4, 1987-1991.
  • Paclitaxel and Cisplatin in Metastatic Breast Cancer

Type of GCP training (e.g. GCP Course, Investigator meeting):

  1. On-site GCP Training received during SIV for all the 36 trials.
  2. Online GCP Training on 30 March 2010
  3. GCP training received during Investigators Meeting for Afatinib Study on13 Jan 2011 in Taipei, Taiwan.
  4. Online GCP Training from Pfizer on 13 Jun 2011.
  5. Online GCP Training from Jhonson & Jhonson on 28 Jun 2011.
  • A KMIO experience, XV APCC Abstract Book 1999, P3-020, Pg.152
  • Itraconozole in Immunocompromised patients.
  • XV APCC Abstract Book 1999, P5 – 074, Pg. 217.

TRAINING

  • Trained in Autologous & Allogenic Stem Cell transplantation in cancer patients at North Western University Hospital, Chicago, U.S.A. (May-June 2003)

BONE MARROW TRANSPLANTATION

  • Successfully performed Autologous Bone Marrow Transplantation for the first time in the state of Karnataka (Feb-Mar 2003).
  • 12 Autologous Bone Marrow Transplantation done in cancer patients till date.

INTRAARTERIAL CHEMOTHERAPY

  • Intraarterial Chemotherapy through the port for Liver Metastasis in Carcinogenic Colon done for the first time in Karnataka – June 2004

CLINICAL TRIALS

Sl.
No		 Year of the Clinical Trial Therapeutic Area Designation in the study
(Principal Investigator, Co Investigator, Study Coordinator etc.)		 Clinical Trial Phase
(0- IV)		 ICH GCP Trial
(Y/N)		 Regulatory details
(FDA / EMEA etc.)
1. 2000-2005 Advanced Ovarian Cancer Co- Investigator II Y DCGI
2. 2001-2005 NSCLC Co- Investigator III Y FDA
3. 2002-2005 Metastatic Breast Cancer Co- Investigator II- III Y FDA
2. 2001-2005 NSCLC Co- Investigator III Y FDA
4. 2002-2005 NSCLC Co- Investigator III Y FDA
5. 2004-2005 Glioblastoma Multiforme Co- Investigator III Y FDA
6. 2004-2006 Breast Cancer Co- Investigator IV Y DCGI
7. 2004-2007 Post Menopausal- Advanced Breast Cancer Co- Investigator IV Y DCGI
8. 2004-2007 GM-CSF Soild tumors Principal Investigator III Y DCGI
9. 2005-2006 G-CSF Co- Investigator II-III Y DCGI
10. 2005- ongoing Metastatic Breast Cancer Principal Investigator III Y FDA
11. 2005-2006 Breast Cancer with Brain Mets Co- Investigator III Y FDA
12. 2005-2007 Breast Cancer Co- Investigator IV Y DCGI
14. 2005-2009 Lung Cancer Co- Investigator III Y FDA
15. 2006-2007 Cancer pain Principal Investigator IIb Y FDA
16. 2006-2007 Thrombocytopenia -Solid tumors Co- Investigator II Y FDA
17. 2006-2007 CA Pancreas Co- Investigator III Y FDA
18. 2006-2007 Bronchoalveolar Carcinoma Co- Investigator II Y FDA
19. 2006-2007 Lung Cancer Co- Investigator III Y FDA
20. 2006-2009 NSCLC Co- Investigator IV Y FDA

[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_message style=”square” message_box_color=”mulled_wine”]For more information, medical assessment and medical quote send your detailed medical history and medical reports as email attachment to Email : – [email protected] Call: +91 9029304141 (10 am. To 8 pm. IST)[/vc_message][/vc_column][/vc_row]